Egg phospholipids

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Egg phospholipids
Accession Number
DB14233
Description

Egg phospholipids are primarily a mixture of naturally occurring phospholipids which are isolated from the egg yolk. Egg phospholipids are available as an intravenous fat emulsion indicated as a source of calories for patients requiring parenteral nutrition.

Type
Biotech
Groups
Approved, Experimental, Investigational
Synonyms
  • Egg lecithin
  • Egg lecithin component of endolipide
  • Egg oil lecithin
  • Egg oil phospholipids
  • Egg phosphatides
  • Egg phospholipid
  • Egg phospholipids
  • Egg yolk lecithin
  • Egg yolk lecithins
  • Egg yolk phosphatides
  • Egg yolk phospholipids
  • Endolipide component egg lecithin
  • Lecithins, egg yolk
  • Phospholipids egg

Pharmacology

Indication

For use as a source of calories for patients requiring parenteral nutrition.

Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
10% Travamulsion Liq IVEgg phospholipids (1.2 g) + Soybean oil (10 g)LiquidIntravenousBaxter Corporation Clintec Nutrition Division1995-12-312015-08-05Canada flag
20% Travamulsion Liq IVEgg phospholipids (1.2 g) + Soybean oil (20 g)LiquidIntravenousBaxter Corporation Clintec Nutrition Division1995-12-312015-08-05Canada flag
Liposyn IIEgg phospholipids (1.2 g/100mL) + Safflower oil (5 g/100mL) + Soybean oil (5 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-08-272011-02-01US flag
Liposyn IIEgg phospholipids (1.2 g/100mL) + Safflower oil (10 g/100mL) + Soybean oil (10 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-08-272011-02-01US flag
Liposyn II 10%Egg phospholipids (0.9 %) + Safflower oil (5 %) + Soybean oil (5 %)EmulsionIntravenousHospira Healthcare Ulc1987-12-312014-08-01Canada flag
Liposyn II 20%Egg phospholipids (1.2 %) + Safflower oil (10 %) + Soybean oil (10 %)EmulsionIntravenousHospira Healthcare Ulc1987-12-312014-08-01Canada flag
Liposyn II Inj 10%Egg phospholipids (700 mg) + Safflower oil (5.0 g) + Soybean oil (5.0 g)EmulsionIntravenousHospira Healthcare Ulc1992-01-012014-08-01Canada flag
Liposyn IIIEgg phospholipids (1.2 g/100mL) + Glycerin (2.5 g/100mL) + Soybean oil (20 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-09-252011-07-01US flag
Liposyn IIIEgg phospholipids (1.2 g/100mL) + Glycerin (2.5 g/100mL) + Soybean oil (10 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-09-242011-07-01US flag
Liposyn IIIEgg phospholipids (1.8 g/100mL) + Glycerin (2.5 g/100mL) + Soybean oil (30 g/100mL)Injection, emulsionIntravenousHospira, Inc.2011-05-012011-06-01US flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
PuralorEgg phospholipids (42.5 mg/1) + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine (5 mg/1) + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine (2.5 mg/1) + Acetylcysteine amide (5 mg/1) + Ascorbic acid (25 mg/1) + Cholecalciferol (100 [iU]/1) + Citric acid (1.6 mg/1) + Cobamamide (2 mg/1) + Folic acid (42.5 mg/1) + Gastric intrinsic factor (2.5 mg/1) + Magnesium L-threonate (2.5 mg/1) + Leucovorin (3 mg/1) + Levomefolic acid (0.4 mg/1) + Magnesium glycinate (1 mg/1) + Niacin (0.5 mg/1) + Pantethine (2.5 mg/1) + Papain (20 mg/1) + Riboflavin (0.5 mg/1) + Sodium citrate (0.8 mg/1) + Thiamine chloride (0.5 mg/1)Tablet, chewableOralCenturion Labs2014-01-012017-09-20US flag

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
1Z74184RGV
CAS number
93685-90-6

References

General References
Not Available
RxNav
349762

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentHippel-Lindau Disease / Renal Cancers1
Not AvailableTerminatedPreventionHypertriglyceridemias1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LiquidIntravenous
Tablet, film coated8000 IU
EmulsionIntravenous
Injection, emulsionIntravenous
CapsuleOral
Injection, emulsionIntravenous2.035 g
Tablet, chewableOral
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US9717852No2017-08-012033-04-08US flag
Additional Data Available
  • Filed On
    Filed On

    The date on which a patent was filed with the relevant government.

    Learn more

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 04, 2018 20:37 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates